Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Sullivan

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Nature Communications|January 2, 2025
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBrandon Zimmerman, Leslie A Dakin, Anne Fortier, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptorKim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Cell Chemical Biology|September 21, 2021
Identification of a PCSK9-LDLR disruptor peptide with in vivo functionMargaret E Brousseau, Kevin B Clairmont, Glen Spraggon, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Nature Communications|January 2, 2025
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBrandon Zimmerman, Leslie A Dakin, Anne Fortier, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptorKim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Cell Chemical Biology|September 21, 2021
Identification of a PCSK9-LDLR disruptor peptide with in vivo functionMargaret E Brousseau, Kevin B Clairmont, Glen Spraggon, et al.
Pageof 8